Efficiency of il-6 inhibitor (olokizumab) in suppressing inflammation in patients with moderate COVID-19 pneumonia

Efficiency of il-6 inhibitor (olokizumab) in suppressing inflammation in patients with moderate COVID-19 pneumonia

Aim. To study the efficiency of IL-6 inhibitor olokizumab in suppressing the inflammation and improving treatment outcomes in patients with moderate COVID-19 pneumonia. Materials and Methods. We enrolled 48 patients with confirmed COVID-19 pneumonia who had indications for the treatment with olokizu...

Full description

Saved in:
Bibliographic Details
Main Authors: N. G. Ganyukova, M. I. Likstanov, M. V. Kosinova, I. N. Kushnir, V. G. Moses, K. B. Moses
Format: Article
Language:Russian
Published: Kemerovo State Medical University 2020-12-01
Series:Фундаментальная и клиническая медицина
Subjects:
covid-19
pneumonia
il-6 inhibitors
Online Access:https://fcm.kemsmu.ru/jour/article/view/328
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items